Supplementary Table1. from PGV001, a Multi-Peptide Personali…

Emerging


0
Citations
0
Refs
2026
Year
Search Works
Work Details
  • DOI 10.1158/2159-8290.32697910
  • OpenAlex ID W7165027792
  • Type Supplementary-materials
  • Language EN
  • Published 17 Jun 2026
  • Added 18 Jun 2026
  • Updated 28 Oct 2026
MENU
0

Supplementary Table1. from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting

Supplementary-materials 2026 EN Gold

Supplementary Table1. Staging at time of enrollment, adjuvant treatment following curative intent treatment until the end of vaccination and vaccination timing

0

Citations

0

References

37

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs

Data: OpenAlex